ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

721
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•31 Dec 2016 06:11

Korea Stock Market Monthly Recap #9 - (December 2016)

The economic hope post Trump win continued to play out in the global equity markets in December. Dow Jones Industrial Average was up 3.3% and...

Logo
598 Views
Share
bullish•Quantitative Analysis
•20 Apr 2026 07:05

KRX Foreign Holding Weekly (Apr 17th): SK Hynix, Doosan Enerbility, Samsung Elec (PREF), APR

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in SK Hynix, Doosan Enerbility, Samsung Elec (PREF),...

Logo
272 Views
Share
•26 Dec 2016 16:13

Free Cash Flow Remains King in Weeding Out the Winners and Losers

The Korean Stock Market remains surprisingly fundamental driven and free cash flow remains a fundamental factor that could help investors to weed...

Logo
484 Views
Share
•23 Dec 2016 07:38

Weeding Out the Chaff for Portfolio Outperformance in 2017

Investors prefer companies that can consistently grow their sales and profits, at reasonable valuations. In this report, we selected 72 companies...

Logo
348 Views
Share
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.2k Views
Share
x